Frequently Asked Questions about the Journal of Informed Pharmacotherapy

What is the JIP?

The JIP is a peer-reviewed online journal dedicated to the practice of rational pharmacotherapy through the use of evidence-based principles.

The JIP fosters the rapid widespread dissemination of original research findings, as well as information intended to help pharmacotherapy practitioners (i.e. pharmacists, physicians, nurses and other health care providers) provide better care for their patients.

Why was the JIP created?

The idea for the Journal arose out of a recognized need for the following:

  • A new peer-reviewed journal that focuses on pharmacotherapy
  • A journal that provides pharmacotherapy literature reviews which highlight, condense, interpret and put this information into proper perspective using evidence-based principles.
  • An alternative to traditional hardcopy distribution to facilitate the rapid and worldwide dissemination of original research activity reports.
  • A journal that is accessible to all, for a price that all can afford

 

What is the history of the JIP?

The idea for the JIP was originated in late 1998 by the Founding Editors (top left of this page). Since then, the Founding Editors have been busy forming an editorial board and the processes by which the JIP will fulfill its mission.

Who is expected to read the JIP?

The JIP is intended for any health care professional with an interest in optimizing pharmacotherapy.

What makes the JIP unique?

JIP is the only peer-reviewed online journal devoted entirely to pharmacotherapy

JIP provides a strong evidence-based perspective through peer-reviewed research and reviews of the pharmacotherapy literature which put the research findings into their proper context

JIP provides a venue for clinicians to widely disseminate research findings (the second it is placed on the Web, it is accessible from any internet terminal on the planet).

JIP provides more rapid dissemination of information than traditional print journals (for example, we expect turnaround time for articles to be a few weeks, vs. a few months for old-style journals)

JIP does not require a paid subscription to access

Is the JIP linked to the Pharmaceutical Industry?

No.  There is no financial relationship between the JIP and any pharmaceutical company.

As with other respected peer-reviewed journals, relationships between authors and such companies must be declared in writing at the time of submission and the details will be provided to the readership in conjunction with any resulting publications.

How is the JIP organized?

The day-to-day operations of the JIP are run by the Founding Editors on a voluntary basis.

Section Editors have been selected based upon their recognized clinical and research expertise in a specific area of pharmacotherapeutics (e.g.. cardiology, infectious diseases, toxicology, etc.)

Section Editors are drawn mainly from the United States and Canada.

Expert reviewers have been drawn from the global pool of pharmacotherapeutics practitioners and researchers.

What are the responsibilities of JIP Section Editors?

As a Section Editor, commitment to the following is required:

  • A new peer-reviewed journal that focuses on pharmacotherapy
  • Coordinate the assessment of submissions related to your area of specialty. This involves approximately 2-3 submissions per year.
  • Identify and facilitate the involvement of 2-3 reviewers for each submission sent to you.
  • Provide your own recommendation as to the suitability of each submission for publication.
  • By invitation or voluntarily provide other input related to your specialty area such as evidence-based reviews of the pharmacotherapeutic literature, reviews of websites or editorials.
  • Provide a review turnaround time of 4 weeks or less to ensure a prompt (but thorough) review of each submission.
  • Be conversant in the use of email (including the ability to send and receive file attachments) and the internet and have ready access to both. All submissions to the Journal must be in Microsoft Word 97/2000 format, so editors/reviewers must have access to and skills in using this word processing software.
  • Be willing to make a one year commitment to participation as a Section Editor.

Although these responsibilities may sound onerous, there are several Section Editors and most of the administrative duties are handled by the Managing/Founding Editors.  Accordingly, the workload for Section Editors should be manageable.

Regardless of whether you are called upon to provide input to the Journal, you would be listed as a Section Editor in all issues of the Journal on the website.

What is the format of the JIP?

Articles will be published on the Web in browser-friendly HTML format and in a downloadable PDF (Adobe Acrobat) document format.

What types of information does the JIP contain?

PEER REVIEWED ORIGINAL RESEARCH ARTICLES

EVIDENCE-BASED REVIEWS OF THE PHARMACOTHERAPEUTIC LITERATURE

Evidence-based reviews of the pharmacotherapeutic literature with emphasis on interpretation of the findings, designed to help practitioners put the findings into proper perspective.  Written by experts in the field.

ISSUES IN PHARMACOTHERAPY PRACTICE

Articles from a variety of sources focusing on therapeutic reviews, practice-related issues, an controversies. These articles undergo editorial review prior to publishing.

RESEARCH ABSTRACTS

An opportunity for researchers to rapidly disseminate their findings in abstract form.

PHARMACOTHERAPY ON THE WEB

Reviews of pharmacotherapy-related websites and other online clinical information resources.  Designed to aid practitioners in finding high-quality information as well as using for the internet to enhance their practice.

E-MAIL TO THE EDITOR

Allows rapid interpretation, criticism, and discussion of articles in the Journal (or otherwise) by readers.

What about Permanence?

One of the primary problems with electronic publication is the difficulty guaranteeing permanence. For many, the fear that a journal may disappear after a short period of publication is enough to deter subscription or submission to that journal. This is particularly a problem for independent journals which often do not have the technical infrastructure or expertise to guarantee permanence.

The JIP will address this issue by using the Journal Backup service provided by the International Consortium for Alternative Academic Publishing (ICAAP) which provides a backup service which ensures the latest version of this publication will always be available at a central location. In addition to ensuring quick access, this also provides the service of ensuring continuity of access even if we discontinue publication.

The site will also be “mirrored” through the ICAAP mirroring service. With this service, I.C.A.A.P. provides fast North American mirrors for international users. Mirrors are essentially duplicate copies of the original publications housed on alternate servers. Users choose the server closest to their geographic location thereby increasing speed of access and visibility.

Why should authors consider submitting articles for publication in the JIP?

If accepted, authors can expect to have their articles available to a worldwide audience within a few weeks of submission

Authors will have their articles reviewed by established experts in their field

Authors can expect to be among-st the first to have articles published in a online peer-reviewed journal

Authors will support the principles of alternative academic publishing, thereby slowing the decay in our university library systems caused by exorbitant subscription fees charged by publication houses for traditional print journals.

How does the JIP peer-review process work?

Articles submitted for peer review will undergo a rigorous traditional peer review process intended to minimize the likelihood of release of scientifically unfounded or biased results while minimizing the time it takes to make valid results available.

Generally, the process looks something like this:

Founding editors review submission for worthiness of external peer-review.

If deemed worthy of peer-review, blinded review by at least two experts in the therapeutic area concerned is conducted.

Feedback from reviewers is received by Founding Editors and publication-worthiness is assessed.

If deemed potentially worthy of publication, comments and suggestions from reviewers are collated and conveyed to the author.

If the author wishes to address the comments / concerns raised by the JIP reviewers, he/she edits the document as appropriate and sends it back to the founding editors.

If the reviewer’s concerns have been substantially addressed, the article undergoes final editing and is released for publication.  If there is still concern that the reviewers comments have not been properly addressed, the article may be sent back to the reviewers for their input.

How are JIP citations referenced and cited?

Since issues of the JIP are dynamic in the sense that they are built up over time as the articles are completed, we have devised a system that should still make it easy to identify and cite JIP articles

Articles published during each calendar quarter (i.e. 3-month period) will be identified by year, issue (1-4) and page numbers according to the Vancouver

Page numbers will be assigned sequentially from the first article in the issue through to the closing date for that issue

How often is the JIP issued?

Unlike traditional print journals, articles in the JIP will be issued on a continuous basis.  As soon as an article has completed the appropriate review process, it will be posted to the JIP website.

Delays related to episodic publishing (e.g. monthly editions) are avoided.

How much does it cost to subscribe to the JIP?

Nothing.  The JIP will be accessible at no cost over the internet.

Users will only be required to have the necessary hardware/software for access purposes.

A free password-based “subscriber” access system may be set up in the future to allow us to track the nature of our readership, however, no information about our readers will be released to any other agency.

Latest Posts

Generic Viagra Online – Alternative for the purchase of Viagra.

The safe use of Kamagra Oral Jelly has been reviewed, recognized and used by many around the world.

The Viagra professional is an improved form of the original Viagra.

Sildenafil citrate is a generic medicine prescribed in cases of erectile dysfunction.

Caverta is available in 20 mg, 50 mg, and 100 mg oral pill

Sildenafil Over The Counter is the same Viagra brand (sildenafil citrate) that we all know, only now purchase is done from online pharmacy stores and shipping to your home with no need for medical prescription.